Captor Capital Obtains Castroville Dispensary Licenses

Captor Capital Corp

C TORONTO, Dec. 13, 2018 (GLOBE NEWSWIRE) — Captor Capital Corp. (“Captor” or the “Company”) (CSE:CPTR; FRANKFURT:NMV; USOTC:NWURF)  is pleased to announce that the Higher Level Castroville dispensary has been awarded both state and local licenses to sell recreational cannabis. The licenses were awarded December 10th and the Company expects the deal to be finalized shortly. The Captor management team is now in the…

Read More

Q BioMed Announces Strategic Partnership with SRI International for Formulation and Preclinical Development of QBM-001 for Pediatric Nonverbal Disorder in Autistic Children

Collaboration with SRI Provides QBioMed Expertise in Formulation Development and Preclinical Work in Autism, as well as CMC and Manufacturing capability NEW YORK, December 12, 2018 — Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, is pleased to announce a collaborative agreement with SRI International to provide formulation development, preclinical development, and early clinical manufacturing of QBM-001, in support…

Read More

ePlay’s Big Shot Beta iPhone App for NBA Fans Gets Updated in Apple App Store

Itunes Big Shot

CALGARY, Alberta, Dec. 04, 2018 (GLOBE NEWSWIRE) — ePlay Digital Inc. (CSE:EPY) (the “Company”or “ePlay”) today announced a series of new games and challenges for Big Shot™ Basketball Beta which are now available in the Apple App Store. The beta version of the app maintains a 4.4 out of 5 rating in Apple’s App Store and now three new daily…

Read More

ePlay’s China Initiatives Continue On Multiple Fronts

ePlay China

Four significant projects identified with multiple partners in China   ePlay Digital Inc . ( CSE:EPY ) today announced that it has signed a number of preliminary agreements to pursue at least four significant sports related projects in China with potentially new strategic partners in China following a series of meetings with Chinese media, gaming, Internet, broadcast, and financing organizations.…

Read More

Q BioMed Inc Announces Acquisition of Cancer Pain Drug Metastron™ from GE Healthcare

Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries in Which Metastron™ is Already Registered and Approved for Sale NEW YORK, November 28, 2018 — Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, is pleased to announce that it has entered into agreement to acquire the metastatic skeletal cancer palliation drug, Metastron™,…

Read More

Strategic Acquisition planned as Captor Capital continues to expand California footprint

Captor Capital Corp

C.CPTR | TORONTO, Nov. 20, 2018 (GLOBE NEWSWIRE) — Captor Capital Corp. (“Captor” or the “Company”) (CSE:CPTR; FRANKFURT:NMV; USOTC:NWURF) is pleased to announce that it has signed a Letter Of Intent to acquire an entity that has submitted an application pending approval for a cannabis dispensary in Santa Barbara County, California (“the Seller”). The transaction is subject to regulatory approval…

Read More

Captor Capital Sells Orange County Retail Location to MedMen

C.CPTR, C.MMEN | TORONTO, Nov. 16, 2018 — Captor Capital Corp. (“Captor” or the “Company”)(CSE:CPTR; FRANKFURT:NMV; USOTC:NWURF) has signed a definitive agreement (“the Agreement”) to sell the retail operations and license for a dispensary location in Santa Ana, California, through an all-stock transaction with MedMen Enterprises Inc. (“MedMen”) (CSE: MMEN; OTCQX: MMNFF; FSE: A2JM6N) valued at approximately US$16 million. The…

Read More

Captor Capital Extracts More Growth

Captor Capital (CSE: CPTR; FRANKFURT: NMV; USOTC: NWURD) continues to grow its position in the cannabis sector. Investors learned that the company successfully sealed the acquisition of Mellow Extracts, LLC (“Mellow”), which will produce ultra-premium oil in a state-of-the-art extraction lab facility in Costa Mesa, California. In addition to this, Mellow will provide oils and premium concentrates to Captor’s retail…

Read More

Lomiko (TSX-V: LMR, OTC: LMRMF, FSE: DH8C) Closes Raise of $ 1,167,552

Lomiko Closes Raise of $ 1,167,552 Lomiko Metals Inc. (“Lomiko”) (TSX-V: LMR, OTC: LMRMF, FSE: DH8C) announces it has closed the 3rd and final tranche of its private placement and will issue 12,400,000 units at $0.05 per unit for proceeds of $620,000. Each unit will be comprised of one share and one share purchase warrant, with each warrant exercisable at…

Read More

Why Invest in a company looking for ‘pencil lead’?

Lomiko TSX

There are times that investments look odd on the surface but make a lot more sense once you perform due diligence. With debate circulating over the production of oil and pipelines in Canada, pencil lead might just be what we need to help move Canada to a ‘green economy’. Graphite pencil lead is only one form of a very common…

Read More